Nykredit A/S’s Thermo Fisher Scientific TMO Stock Holding History

Nykredit A/S’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53.9M	Buy	+107,565	New	+$51.6M	0.21%	95

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Nykredit A/S's TMO Position: Q2 2026 in Review

Nykredit A/S opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 107,565 shares worth $53.9M. The stake represents 0.21% of the portfolio and ranks #95 among its holdings.

2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Nykredit A/S held 107,565 shares of Thermo Fisher Scientific worth $53.9M as of Q2 2026.
Thermo Fisher Scientific was a new Nykredit A/S position in Q2 2026.
Thermo Fisher Scientific made up 0.21% of Nykredit A/S's portfolio in Q2 2026, its #95 holding.
2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.